Ensign Peak Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Hold |
|
|||||
|
2025
Q1 | $9.62M | Buy |
|
|||||
|
2024
Q4 | $306K | Sell |
|
|||||
|
2024
Q3 | $445K | Sell |
|
|||||
|
2024
Q2 | $422K | Sell |
|
|||||
|
2024
Q1 | $10.2M | Hold |
|
|||||
|
2023
Q4 | $8.51M | Hold |
|
|||||
|
2023
Q3 | $6.32M | Sell |
|
|||||
|
2023
Q2 | $6.04M | Hold |
|
|||||
|
2023
Q1 | $7.26M | Hold |
|
|||||
|
2022
Q4 | $8.27M | Buy |
|
|||||
|
2022
Q3 | $2.38M | Hold |
|
|||||
|
2022
Q2 | $2.14M | Buy |
|
|||||
|
2022
Q1 | $1.97M | Sell |
|
|||||
|
2021
Q4 | $2.73M | Buy |
|
|||||
|
2021
Q3 | $2.82M | Sell |
|
|||||
|
2021
Q2 | $3.77M | Sell |
|
|||||
|
2021
Q1 | $8.62M | Buy |
|
|||||
|
2020
Q4 | $6.39M | Sell |
|
|||||
|
2020
Q3 | $7.88M | Buy |
|
|||||
|
2020
Q2 | $6.75M | Buy |
|
|||||
|
2020
Q1 | $4.84M | Sell |
|
|||||
|
2019
Q4 | $6.86M | Buy |
|